COVID-19 and the Otolaryngologist: Preliminary Evidence-Based Review.
The SARS-CoV-2 virus, which causes coronavirus disease 2019 (COVID-19), has rapidly swept across the world since its identification in December 2019. Otolaryngologists are at unique risk due to the close contact with mucus membranes of the upper respiratory tract and have been among the most affected healthcare workers in Wuhan, China. We present information on COVID-19 management relevant to otolaryngologists on the frontlines of this pandemic and provide preliminary guidance based on practices implemented in China and other countries and practical strategies deployed at Stanford University. Laryngoscope, 130:2537-2543, 2020.
['Vukkadala|Neelaysh|N|0000-0003-1787-935X', 'Qian|Z Jason|ZJ|0000-0003-4150-1023', 'Holsinger|F Christopher|FC|0000-0002-9594-1414', 'Patel|Zara M|ZM|0000-0003-2072-982X', 'Rosenthal|Eben|E|0000-0003-0294-5203']
D000086382:COVID-19 D002681:China D018562:Disease Transmission, Infectious D006801:Humans D016273:Occupational Exposure D000072220:Otolaryngologists D017410:Practice Guidelines as Topic D000086402:SARS-CoV-2
COVID-19 SARS-CoV-2 clinical practice guidelines evidence-based medicine infectious disease